204 related articles for article (PubMed ID: 34984624)
1. Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
Aouchiche K; Reynaud R; Amodru V; Brue T; Cuny T
Endocrine; 2022 Apr; 76(1):179-188. PubMed ID: 34984624
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide.
Díaz-Soto G; Mora-Porta M; Nicolau J; Perea V; Halperin I; Puig-Domingo M
Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758
[TBL] [Abstract][Full Text] [Related]
4. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.
Saraiva M; Chaves AC; Assunção G; Saraiva J; Carvalho R
Am J Case Rep; 2021 Aug; 22():e931739. PubMed ID: 34389697
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoparathyroidism and treatment with teriparatide.
Marcucci G; Masi L; Cianferotti L; Giusti F; Fossi C; Parri S; Gronchi G; Brandi ML
Endocrine; 2021 Apr; 72(1):249-259. PubMed ID: 33538953
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous rhPTH infusion for managing difficult chronic hypoparathyroidism. A systematic review.
Gamarra E; Retta F; Lucatello B; Ragazzoni F; Camponovo C; Deandrea M; Trimboli P
Endocrine; 2023 Aug; 81(2):194-205. PubMed ID: 37017857
[TBL] [Abstract][Full Text] [Related]
7. Improving management of severe hypoparathyroidism: a case series.
Ugalde-Abiega B; Lamas Oliveira C; Alfaro Martínez JJ; Meizoso-Pita O; Sevillano Collantes C; Gomez García I; Perez Rodríguez A; Huguet I
Hormones (Athens); 2022 Mar; 21(1):71-77. PubMed ID: 34647284
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe life threatening hypocalcemia with recombinant human teriparatide in patients with postoperative hypoparathyroidism - a case series.
Andrysiak-Mamos E; Żochowska E; Kaźmierczyk-Puchalska A; Popow M; Kaczmarska-Turek D; Pachucki J; Bednarczuk T; Syrenicz A
Endokrynol Pol; 2016; 67(4):403-12. PubMed ID: 27387245
[TBL] [Abstract][Full Text] [Related]
9. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
Bislev LS; Sikjaer T; Rejnmark L
Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
[TBL] [Abstract][Full Text] [Related]
10. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
Angelopoulos NG; Goula A; Tolis G
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236
[TBL] [Abstract][Full Text] [Related]
11. Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism.
Tuli G; Buganza R; Tessaris D; Einaudi S; Matarazzo P; de Sanctis L
Endocrine; 2020 Feb; 67(2):457-465. PubMed ID: 31705387
[TBL] [Abstract][Full Text] [Related]
12. [Reduction in requirements of oral calcium and 1-25 dihydroxy vitamin D in patients with post-surgical hypoparathyroidism treated with teriparatide (PTH1-34)].
Gutiérrez-Cerecedo LE; Vergara-López A; Rosas-Barrientos JV; Guillén-González MÁ
Gac Med Mex; 2016; 152(3):322-8. PubMed ID: 27335186
[TBL] [Abstract][Full Text] [Related]
13. Use of parathyroid hormone in hypoparathyroidism.
Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
[TBL] [Abstract][Full Text] [Related]
17. PTH treatment in hypoparathyroidism.
Sikjaer T; Rejnmark L; Mosekilde L
Curr Drug Saf; 2011 Apr; 6(2):89-99. PubMed ID: 21524246
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
Winer KK; Ko CW; Reynolds JC; Dowdy K; Keil M; Peterson D; Gerber LH; McGarvey C; Cutler GB
J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism.
Shah M; Bancos I; Thompson GB; Richards ML; Kasperbauer JL; Clarke BL; Drake MT; Stan MN
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):822-7. PubMed ID: 26312597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
